Analyze Diet
Frontiers in veterinary science2024; 11; 1461648; doi: 10.3389/fvets.2024.1461648

Pharmacokinetics and thermal anti-nociceptive effects of oral morphine in horses.

Abstract: Morphine is an effective analgesic in horses, however, IV administration at therapeutic doses has been shown to produce dose-dependent neuroexcitation and unwanted gastrointestinal effects. The analgesic effects of morphine have, at least in part, been attributed to the morphine-6-glucuronide (M6G) metabolite. Oral administration to horses results in comparable M6G concentrations to that achieved following IV administration of a therapeutic dose without the adverse effects. The anti-nociceptive effects have not yet been reported. In the current study the thermal anti-nociceptive effects of single and multiple oral doses of morphine were assessed. Unassigned: Six horses received a single 0.2 mg/kg IV dose of morphine and multiple oral doses of 0.8 mg/kg morphine every 12 h for 4.5 days. Blood samples were collected throughout administration, morphine, and metabolite concentrations determined and pharmacokinetic analysis performed. Drug related behavior and physiologic responses were recorded. Response to noxious stimuli was evaluated by determining thermal threshold latency in response to the application of heat. Unassigned: The maximum concentrations of M6G were higher following oral administration compared to IV and the combined morphine and M6G concentrations exceeded that of IV administration starting at 2 h. Oral administration of 0.8 mg/kg morphine provided and maintained comparable anti-nociception effects to IV morphine with less adverse effects, following single and multiple doses. Morphine was well tolerated following oral administration with less excitation and minimal effects on gastrointestinal borborygmi scores compared to IV administration. Unassigned: Results of the current study warrant further investigation of the anti-nociceptive effects of oral morphine administration to horses.
Publication Date: 2024-09-17 PubMed ID: 39355143PubMed Central: PMC11443510DOI: 10.3389/fvets.2024.1461648Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the pharmacokinetics and analgesic effects of oral morphine in horses and shows that oral administration of morphine is effective and has fewer side effects compared to intravenous administration.

Introduction

  • The article starts by stating the primary purpose of the study: to assess the analgesic effects and pharmacokinetics of oral morphine administration in horses. It provides a background where it mentions that although morphine is an effective analgesic for horses, its intravenous administration can lead to undesirable side effects like neuroexcitation and gastrointestinal issues.
  • The article also explains that a metabolite of morphine, morphine-6-glucuronide (M6G), is partly responsible for the pain relief property of morphine. The researchers were looking to observe if oral administration produces comparable M6G levels as intravenous administration, but without the adverse effects.

Methods

  • In this study, six horses were used as subjects. A single 0.2 mg/kg intravenous dose of morphine was given, and then multiple oral doses of 0.8 mg/kg morphine were administered every 12 hours for 4.5 days.
  • Blood samples were collected throughout this period. The concentration of morphine and its metabolites was determined, and a pharmacokinetic analysis was performed. Observations were also made on the horses’ behavior and physiological responses.
  • Anti-nociceptive effects were assessed by application of heat and monitoring for thermal threshold latency in response to the stimuli.

Results

  • The results show that the maximum concentrations of M6G were higher following oral administration compared to intravenous administration. Also, the combined concentrations of morphine and M6G exceeded that after intravenous administration, starting at 2 hours.
  • The study suggests that oral administration of 0.8 mg/kg morphine provided comparable pain relief to intravenous morphine, with fewer adverse effects, after single and multiple doses.
  • The reaction of the horses to oral administration of morphine was positive, with lesser excitation and minimal effects on gastrointestinal scores compared to intravenous administration.

Conclusion

  • The conclusion drawn from the study is that the results warrant further investigation of the pain-relief effects of oral morphine administration to horses.

Cite This Article

APA
Knych HK, Steinmetz SJ, Traynham ML, McKemie DS, Kass PH. (2024). Pharmacokinetics and thermal anti-nociceptive effects of oral morphine in horses. Front Vet Sci, 11, 1461648. https://doi.org/10.3389/fvets.2024.1461648

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 11
Pages: 1461648
PII: 1461648

Researcher Affiliations

Knych, Heather K
  • K.L. Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
  • Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Steinmetz, Stacy J
  • K.L. Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Traynham, Megan L
  • K.L. Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
McKemie, Daniel S
  • K.L. Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Kass, Philip H
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared HS was an editorial member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

References

This article includes 27 references
  1. Knych HK, Steffey EP, McKemie DS. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.. J Vet Pharmacol Ther (2014) 37:12098.
    doi: 10.1111/jvp.12098pubmed: 24479785google scholar: lookup
  2. Hamamoto-Hardman BD, Steffey EP, Weiner D, McKemie DS, Kass P, Knych HK. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses.. J Vet Pharmacol Ther (2019) 42:12759.
    doi: 10.1111/jvp.12759pubmed: 30919469google scholar: lookup
  3. Combie J, Shults T, Nugent EC, Dougherty J, Tobin T. Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity.. Am J Vet Res (1981) 42:716–21.
    pubmed: 6114692
  4. Bennett RC, Steffey EP. Use of opioids for pain and anesthetic management in horses.. Vet Clin North Am Equine Pract (2002) 18:47–60.
    doi: 10.1016/s0749-0739(02)00011-1pubmed: 12064182google scholar: lookup
  5. Figueiredo JP, Muir WW, Sams R. Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses.. Am J Vet Res (2012) 73:799–808.
    doi: 10.2460/ajvr.73.6.799pubmed: 22620693google scholar: lookup
  6. Poth MKM, McKemie DS, Traynham M, Kass PH, Knych HK. Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses.. J Vet Pharmacol Ther (2023) 46:238–49.
    doi: 10.1111/jvp.13122pubmed: 36883679google scholar: lookup
  7. Bowsher D. Paradoxical pain.. BMJ (Clinical research ed) (1993) 306:473–4.
    doi: 10.1136/bmj.306.6876.473pmc: PMC1676821pubmed: 8448453google scholar: lookup
  8. Janicki PK. Pharmacology of morphine metabolites.. Curr Pain Headache Rep (1997) 1:264–70.
  9. Thomas J, Corson NI, Meinhold A, Both CP. Neurological excitation in a 6-week-old male infant after morphine overdose.. Paediatr Anaesth (2019) 29:1060–1.
    doi: 10.1111/pan.13723pubmed: 31433900google scholar: lookup
  10. Knych HK, Kanarr K, Fang Y, McKemie DS, Kass PH. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses.. Vet Anaesth Analg (2022) 7:e6.
    doi: 10.1016/j.vaa.2022.07.006pubmed: 35999165google scholar: lookup
  11. Hanna MH, Peat SJ, Knibb AA, Fung C. Disposition of morphine-6-glucuronide and morphine in healthy volunteers.. Br J Anaesth (1991) 66:103–7.
    doi: 10.1093/bja/66.1.103pubmed: 1997044google scholar: lookup
  12. Osborne R, Thompson P, Joel S, Trew D, Patel N, Slevin M. The analgesic activity of morphine-6-glucuronide.. Br J Clin Pharmacol (1992) 34:130–8.
  13. Stain F, Barjavel MJ, Sandouk P, Plotkine M, Scherrmann JM, Bhargava HN. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.. J Pharmacol Exp Ther (1995) 274, 852–7.
    pubmed: 7636748
  14. Hanna MH, Elliott KM, Fung M. Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery.. Anesthesiology (2005) 102:815–21.
  15. Romberg R, van Dorp E, Hollander J, Kruit M, Binning A, Smith T. A randomized, double-blind, placebo-controlled pilot study of IV morphine-6-glucuronide for postoperative pain relief after knee replacement surgery.. Clin J Pain (2007) 23:197–203.
    doi: 10.1097/AJP.0b013e31802b4f6apubmed: 17314577google scholar: lookup
  16. Knych HK, Kanarr K, Fang Y, McKemie DS, Kass PH. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses.. Vet Anaesth Analg (2022) 49:634–44.
    doi: 10.1016/j.vaa.2022.07.00pubmed: 35999165google scholar: lookup
  17. Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.. Br J Anaesth (2014) 113:e186.
    doi: 10.1093/BJA/AEU186pubmed: 24985077google scholar: lookup
  18. Hanks GW, Hoskin PJ, Aherne GW, Turner P, Poulain P. Explanation for potency of repeated oral doses of morphine?. Lancet (1987) 2:723–5.
    doi: 10.1016/s0140-6736(87)91083-xpubmed: 2888950google scholar: lookup
  19. Lötsch J, Weiss M, Ahne G, Kobal G, Geisslinger G. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.. Anesthesiology (1999) 90:1026–38.
  20. Hamamoto-Hardman BD, Steffey EP, Seminoff K, McKemie DS, Kass P, Knych HK. Preliminary study of the pharmacokinetics, tissue distribution, and behavioral and select physiological effects of morphine 6-glucuronide (M6G) following intravenous administration to horses.. Can J Vet Res (2022) 86:172–80.
    pmc: PMC9251799pubmed: 35794968
  21. Hill R, Canals M. Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology.. Pharmacol Ther (2022) 230:107961.
  22. Söbbeler FJ, Kästner SB. Effects of transdermal lidocaine or lidocaine with prilocaine or tetracaine on mechanical superficial sensation and nociceptive thermal thresholds in horses.. Vet Anaesth Analg (2018) 45:227–33.
    doi: 10.1016/j.vaa.2017.10.003pubmed: 29415859google scholar: lookup
  23. Combie JD, Nugent TE, Tobin T. Pharmacokinetics and protein binding of morphine in horses.. Am J Vet Res (1983) 44:870–4.
    pubmed: 6869996
  24. Dönselmann Im Sande P, Hopster K, Kästner S. Effects of morphine, butorphanol and levomethadone in different doses on thermal nociceptive thresholds in horses.. Tierarztl Prax Ausg G Grosstiere Nutztiere (2017) 45:98–106.
    doi: 10.15653/TPG-160655pubmed: 28075433google scholar: lookup
  25. Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.. Anaesth Intensive Care (2012) 40:216–35.
    doi: 10.1177/0310057X1204000204pubmed: 22417016google scholar: lookup
  26. Duke-Novakovski T, Jimenez CP, Fujiyama M, Beazley SG. Plasma histamine concentrations in horses administered sodium penicillin, guaifenesin-xylazine-ketamine and isoflurane with morphine or butorphanol.. Vet Anaesth Analg (2021) 48:17–25.
    doi: 10.1016/j.vaa.2020.10.003pubmed: 33229232google scholar: lookup
  27. Guedes AGP, Rudé EP, Rider MA. Evaluation of histamine release during constant rate infusion of morphine in dogs.. Vet Anaesth Analg (2006) 33:28–35.

Citations

This article has been cited 0 times.